Literature DB >> 20817537

Traumatic interhemispheric subdural haematoma: Study of 35 cases.

Satoru Takeuchi1, Yoshio Takasato, Hiroyuki Masaoka, Takanori Hayakawa, Hiroshi Yatsushige, Takashi Sugawara.   

Abstract

The clinical and radiological findings, management, and outcomes in 35 patients with traumatic interhemispheric subdural haematoma (ISH) were reviewed retrospectively. Twenty-five patients had favourable outcomes and 10 had poor outcomes. All patients were treated conservatively for ISH. Univariate analysis found that the Glasgow Coma Scale (GCS) score (p < 0.001), hypovolemic shock (p = 0.018), skull fracture (p = 0.008), convexity or posterior fossa subdural haematoma (p = 0.008), and subarachnoid haemorrhage (SAH) were correlated with outcome (p < 0.001). Multivariate analysis showed that GCS score (p = 0.031; odds ratio [OR], 0.6; 95% confidence interval [CI], 0.3-0.9) and the presence of SAH (p = 0.023; OR, 14.2; 95% CI, 1.5-138.2) were significantly related to poor outcome. This study provides important information on the clinicoradiological findings and prognoses in patients with traumatic ISH. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20817537     DOI: 10.1016/j.jocn.2010.03.055

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  A case of traumatic acute interhemispheric subdural hematoma due to injured dural branch of anterior cerebral artery.

Authors:  Hideki Nakajima; Takuro Tsuchiya; Shigetoshi Shimizu; Hidenori Suzuki
Journal:  Surg Neurol Int       Date:  2022-08-12

2.  Clinical Features of Interhemispheric Subdural Hematomas.

Authors:  Jae-Min Ahn; Kyeong-Seok Lee; Jae-Hyun Shim; Jae-Sang Oh; Jai-Joon Shim; Seok-Mann Yoon
Journal:  Korean J Neurotrauma       Date:  2017-10-31

Review 3.  Clinical Characteristics and Outcome in Elderly Patients with Traumatic Brain Injury: For Establishment of Management Strategy.

Authors:  Hiroshi Karibe; Toshiaki Hayashi; Ayumi Narisawa; Motonobu Kameyama; Atsuhiro Nakagawa; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-07-05       Impact factor: 1.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.